Status:
COMPLETED
Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia
Lead Sponsor:
Eastern Cooperative Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Leukemia
Eligibility:
All Genders
61-120 years
Brief Summary
RATIONALE: Studying blood samples from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This rese...
Detailed Description
OBJECTIVES: * Delineate the spectrum of genetic and epigenetic lesions occurring in elderly patients with acute myeloid leukemia (AML). * Determine the biological functions perturbed by these lesions...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Subset of patients diagnosed with acute myeloid leukemia (AML) enrolled on E3999
- AML resistant or sensitive to chemotherapy
- Mononuclear cell samples available
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
August 17 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 17 2011
Estimated Enrollment :
257 Patients enrolled
Trial Details
Trial ID
NCT01421875
Start Date
August 17 2011
End Date
October 17 2011
Last Update
May 17 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.